Cargando...
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still conce...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2018
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516871/ https://ncbi.nlm.nih.gov/pubmed/30560579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|